Seroprevalence of Bordetella pertussis Infection in Patients With Chronic Obstructive Pulmonary Disease in England: Analysis of the AERIS Cohort

References

• Kandeil W, Atanasov P, Avramioti D, et al. The burden of pertussis in older adults: what is the role of vaccination? A systematic literature review. Expert Rev Vaccines. 2019;18(5):439–455.
   PubMed Web of Science ®Google Scholar
• Kandeil W, van den Ende C, Bunge EM, et al. A systematic review of the burden of pertussis disease in infants and the effectiveness of maternal immunization against pertussis. Expert Rev Vaccines. 2020;19(7):621–638.
   PubMed Web of Science ®Google Scholar
• Yeung KHT, Duclos P, Nelson EAS, et al. An update of the global burden of pertussis in children younger than 5 years: a modelling study. Lancet Infect Dis. 2017;17(9):974–980.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Pertussis vaccines: WHO position paper – September 2015. Wkly Epidemiol Rec. 2015;90(35):433–458.
   PubMedGoogle Scholar
• Jenkins VA, Savic M, Kandeil W. Pertussis in high-risk groups: an overview of the past quarter-century. Hum Vaccin Immunother. 2020;16(11):2609–2617.
   PubMed Web of Science ®Google Scholar
• Moore A, Harnden A, Grant CC, et al. Clinically diagnosing pertussis-associated cough in adults and children: CHEST guideline and expert panel report. Chest. 2019;155(1):147–154.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Laboratory manual for the diagnosis of whooping cough caused by Bordetella pertussis/Bordetella parapertussis 2014. [cited 2021 Jan 8]. Available from: https://apps.who.int/iris/bitstream/handle/10665/127891/WHO_IVB_14.03_eng.pdf.
   Google Scholar
• GBD, 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Watz H. Chronic obstructive pulmonary disease. Lancet. 2017;389(10082):1931–1940.
   PubMed Web of Science ®Google Scholar
• Jafarinejad H, Moghoofei M, Mostafaei S, et al. Worldwide prevalence of viral infection in AECOPD patients: a meta-analysis. Microb Pathog. 2017;113:190–196.
   PubMed Web of Science ®Google Scholar
• Moghoofei M, Azimzadeh Jamalkandi S, Moein M, et al. Bacterial infections in acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. Infection. 2020;48(1):19–35.
   PubMed Web of Science ®Google Scholar
• Ko FW, Chan KP, Hui DS, et al. Acute exacerbation of COPD. Respirology. 2016;21(7):1152–1165.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57(10):847–852.
   PubMed Web of Science ®Google Scholar
• Dransfield MT, Kunisaki KM, Strand MJ, COPDGene Investigators, et al. Acute exacerbations and lung function loss in smokers with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2017;195(3):324–330.
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ferrer M, Pont A, et al. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004;59(5):387–395.
   PubMed Web of Science ®Google Scholar
• Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5):1418–1422.
   PubMed Web of Science ®Google Scholar
• Soler-Cataluña JJ, Martínez-García MA, Román SP, et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 2005;60(11):925–931.
   PubMed Web of Science ®Google Scholar
• Iheanacho I, Zhang S, King D, et al. Economic burden of chronic obstructive pulmonary disease (COPD): a systematic literature review. Int J Chron Obstruct Pulmon Dis. 2020;15:439–460.
   PubMed Web of Science ®Google Scholar
• Chapman KR, Mannino DM, Soriano JB, et al. Epidemiology and costs of chronic obstructive pulmonary disease. Eur Respir J. 2006;27(1):188–207.
   PubMed Web of Science ®Google Scholar
• Buck PO, Meyers JL, Gordon LD, et al. Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims. Epidemiol Infect. 2017;145(10):2109–2121.
   PubMed Web of Science ®Google Scholar
• Mbayei SA, Faulkner A, Miner C, et al. Severe pertussis infections in the United States, 2011–2015. Clin Infect Dis. 2019;69(2):218–226.
   PubMed Web of Science ®Google Scholar
• Blasi F, Bonanni P, Braido F, et al. The unmet need for pertussis prevention in patients with chronic obstructive pulmonary disease in the Italian context. Hum Vaccin Immunother. 2020;16(2):340–348.
   PubMed Web of Science ®Google Scholar
• Bonhoeffer J, Bär G, Riffelmann M, et al. The role of Bordetella infections in patients with acute exacerbation of chronic bronchitis. Infection. 2005;33(1):13–17.
   PubMed Web of Science ®Google Scholar
• Bourne S, Cohet C, Kim V, et al. Acute exacerbation and respiratory infections in COPD (AERIS): protocol for a prospective, observational cohort study. BMJ Open. 2014;4(3):e004546.
   PubMed Web of Science ®Google Scholar
• Wilkinson TMA, Aris E, Bourne S, AERIS Study Group, et al. A prospective, observational cohort study of the seasonal dynamics of airway pathogens in the aetiology of exacerbations in COPD. Thorax. 2017;72(10):919–927.
   PubMed Web of Science ®Google Scholar
• Barkoff AM, Gröndahl-Yli-Hannuksela K, He Q. Seroprevalence studies of pertussis: what have we learned from different immunized populations. Pathog Dis. 2015;73(7):ftv050.
   PubMed Web of Science ®Google Scholar
• Guiso N, Berbers G, Fry NK, EU Pertstrain group, et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis. 2011;30(3):307–312.
   PubMed Web of Science ®Google Scholar
• European Centre for Disease Prevention and Control. Guidance and protocol for the serological diagnosis of human infection with Bordetella pertussis 2012. [cited 2020 Nov 27]. Available from: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/bordetella-pertussis-guidance-protocol-serological-diagnosis.pdf.
   Google Scholar
• World Health Organization. The immunological basis for immunization series: module 4: pertussis. update 2017 ed. Geneva: World Health Organization; 2017.
   Google Scholar
• Public Health England. Guidelines for the Public Health Management of Pertussis in England 2018. [cited 2020 Nov 27]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/762766/Guidelines_for_the_Public_Health_management_of_Pertussis_in_England.pdf.
   Google Scholar
• Mayhew D, Devos N, Lambert C, AERIS Study Group, et al. Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax. 2018;73(5):422–430. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945&from=EN#page=32
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Global Initiative for Chronic Obstructive Lung Disease, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2007;176(6):532–555.
   PubMed Web of Science ®Google Scholar
• Public Health England. Pertussis: the green book, chapter 24 2016. [cited 2020 Nov 27]. Available from: https://www.gov.uk/government/publications/pertussis-the-green-book-chapter-24.
   Google Scholar
• Kovac M, Kostanyan L, Mesaros N, et al. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study. Hum Vaccin Immunother. 2018;14(8):1977–1986.
   PubMed Web of Science ®Google Scholar
• van der Zee A, Schellekens JF, Mooi FR. Laboratory diagnosis of pertussis. Clin Microbiol Rev. 2015;28(4):1005–1026.
   PubMed Web of Science ®Google Scholar
• Ausiello CM, Stefanelli P, Carollo M, et al. Pertosse in Italia: ricognizione dei laboratori di diagnosi del Servizio Sanitario Nazionale e valutazione delle tecniche utilizzate (Rapporti ISTISAN 14/3 - Istituto Superiore di Sanita) [Pertussis in Italy: identification of the National Health Service laboratories performing pertussis diagnosis and evaluation of used procedures] 2014. [cited 2020 Nov 27]. Available from: https://www.iss.it/documents/20126/45616/14_3.pdf/.
   Google Scholar
• Aris E, Akpo EI, Bhavsar A, et al. Late Breaking Abstract - Burden of pertussis in COPD: a retrospective database study in England. Eur Respir J. 2020. 56(suppl 64):2468.
   Google Scholar
• Kim VL, Coombs NA, Staples KJ, et al. Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort. Eur Respir J. 2017;50(4):1700853.
   PubMed Web of Science ®Google Scholar
• Bafadhel M, McKenna S, Terry S, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–671.
   PubMed Web of Science ®Google Scholar
• Public Health England. Laboratory confirmed cases of pertussis in England. Annual report for 2019 supplementary data tables 2020. [cited 2020 Nov 27]. Available from: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/881410/Laboratory_confirmed_cases_of_pertussis_in_England_2019.pdf.
   Google Scholar
• Kolsum U, Donaldson GC, Singh R, et al. Blood and sputum eosinophils in COPD; relationship with bacterial load. Respir Res. 2017;18(1):88.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Pertussis. Diagnosis confirmation 2019. [cited 2020 Oct 27]. Available from: https://www.cdc.gov/pertussis/clinical/diagnostic-testing/diagnosis-confirmation.html.
   Google Scholar
• European Union. Commission implementing decision (EU) 2018/945 of 22 June 2018. on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions. 3.30 Pertussis 2018 [cited 2020 Oct 27]. Available from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32018D0945&from=EN#page=32.:32018D0945&from = EN#page=32
   Google Scholar
• World Health Organization. Vaccine-preventable diseases surveillance standards: Pertussis [cited 2020 Oct 27]. Available from: https://www.who.int/immunization/monitoring_surveillance/burden/vpd/WHO_SurveillanceVaccinePreventable_16_Pertussis_R1.pdf?ua=1.
   Google Scholar
• Ben Fraj I, Smaoui H, Zghal M, et al. Seroprevalence of pertussis among healthcare workers: a cross-sectional study from Tunisia. Vaccine. 2019;37(1):109–112.
   PubMed Web of Science ®Google Scholar
• Palazzo R, Carollo M, Fedele G, et al. Evidence of increased circulation of Bordetella pertussis in the Italian adult population from seroprevalence data (2012-2013). J Med Microbiol. 2016;65(7):649–657.
   PubMed Web of Science ®Google Scholar
• Rønn PF, Dalby T, Simonsen J, et al. Seroepidemiology of pertussis in a cross-sectional study of an adult general population in Denmark. Epidemiol Infect. 2014;142(4):729–737.
   PubMed Web of Science ®Google Scholar
• Wanlapakorn N, Ngaovithunvong V, Thongmee T, et al. Seroprevalence of antibodies to pertussis toxin among different age groups in Thailand after 37 years of universal whole-cell pertussis vaccination. PLoS One. 2016;11(2):e0148338.
   PubMed Web of Science ®Google Scholar
• Xu Y, Wang L, Xu J, et al. Seroprevalence of pertussis in China: need to improve vaccination strategies. Hum Vaccin Immunother. 2014;10(1):192–198.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Zheng H, Liu M, et al. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross sectional study. BMC Infect Dis. 2012;12:138.
   PubMed Web of Science ®Google Scholar
• Scott S, van der Sande M, Faye-Joof T, et al. Seroprevalence of pertussis in the Gambia: evidence for continued circulation of bordetella pertussis despite high vaccination rates. Pediatr Infect Dis J. 2015;34(4):333–338.
   PubMed Web of Science ®Google Scholar
• Torzsa P, Devadiga R, Tafalla M. Seroprevalence of Bordetella pertussis antibodies in adults in Hungary: results of an epidemiological cross-sectional study. BMC Infect Dis. 2017;17(1):242.
   PubMedGoogle Scholar
• Garcı́a-Corbeira P, Dal-Ré R, Aguilar L, et al. Seroepidemiology of Bordetella pertussis infections in the Spanish population: a cross-sectional study. Vaccine. 2000;18(21):2173–2176.
   PubMed Web of Science ®Google Scholar
• de Greeff SC, de Melker HE, van Gageldonk PG, et al. Seroprevalence of pertussis in The Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One. 2010;5(12):e14183.
   PubMed Web of Science ®Google Scholar
• de Melker HE, Versteegh FGA, Schellekens JFP, et al. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. J Infect. 2006;53(2):106–113.
   PubMed Web of Science ®Google Scholar
• He H, Yao P, Zhou Y, et al. Is pertussis infection neglected in China? Evidence from a seroepidemiology survey in Zhejiang, an eastern province of China. PLoS One. 2016;11(5):e0155965.
   PubMed Web of Science ®Google Scholar
• Wilkinson TMA, Aris E, Bourne SC, et al. Drivers of year-to-year variation in exacerbation frequency of COPD: analysis of the AERIS cohort. ERJ Open Res. 2019;5(1):00248-2018.
   PubMedGoogle Scholar
• Hirai K, Homma T, Yamaguchi F, et al. Acute exacerbation of idiopathic pulmonary fibrosis induced by pertussis: the first case report. BMC Pulm Med. 2019;19(1):15.
   PubMedGoogle Scholar
• Bos AC, Beemsterboer P, Wolfs TF, et al. Bordetella species in children with cystic fibrosis: what do we know? The role in acute exacerbations and chronic course. J Cyst Fibros. 2011;10(5):307–312.
   PubMed Web of Science ®Google Scholar
• Murris M, Guiso N, Njamkepo E, et al. Whooping cough in cystic fibrosis (CF). Eur Respir J. 2011;38(Suppl 55):p 4563.
   Google Scholar
• Liu BC, He WQ, Newall AT, et al. Effectiveness of acellular pertussis vaccine in older adults: Nested matched case-control study. Clin Infect Dis. 2020;71(2):340–350.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease – 2021 report [cited 2021 Jan 8]. Available from: https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf.
   Google Scholar
• Centers for Disease Control and Prevention. Vaccine information for adults. Recommended vaccines for adults with health conditions: lung disease including asthma and adult vaccination 2016. [cited 2021 Jan 8]. Available from: https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/lung-disease.html.
   Google Scholar